Related Experiment Videos
Tianeptine therapy for depression in the elderly
J Saiz-Ruiz1, J M Montes, E Alvarez
1Hospital Ramón y Cajal, Madrid, Spain. jeronimo.saiz@hrc.es
Summary
This study found that tianeptine, a novel antidepressant, effectively treated depression in elderly patients. The medication demonstrated significant symptom reduction and was well-tolerated, with minimal side-effects in this population.
Area of Science:
- Geriatric Psychiatry
- Pharmacology
Background:
- Depression is common in the elderly, presenting diagnostic and treatment challenges.
- Tianeptine offers a novel antidepressant mechanism, distinct from SSRIs, with demonstrated efficacy and safety.
Purpose of the Study:
- To evaluate the efficacy and tolerability of tianeptine in elderly patients with depressive symptoms.
- To assess the impact of tianeptine on anxiety and cognitive function in this demographic.
Main Methods:
- An open-label, 3-month, multicenter study involving 63 elderly patients (mean age 68.8 years) with major depression or dysthymia.
- Patients received tianeptine 25 mg daily.
- Depressive symptoms were assessed using the Montgomery and Asberg Depression Rating Scale.
Main Results:
- Significant reduction in Montgomery and Asberg Depression Rating Scale scores by day 14 (p < 0.01), with a 76.7% response rate.
- 43 patients (68.2%) completed the study without dropouts due to side-effects.
- Improvements noted in anxiety and cognitive performance; only 11.7% experienced side-effects, with no safety parameter changes.
Conclusions:
- Tianeptine is an effective and well-tolerated antidepressant treatment for elderly patients.
- The study supports tianeptine's utility in managing geriatric depression, anxiety, and cognitive deficits.